Nonalcoholic steatosis

P88 Vascular adhesion protein-1 (VAP-1) modulates glucose and lipid uptake in Non-Alcoholic Fatty Liver Disease (NAFLD)
S Karim, E Liaskou, J Youster, Fei-L Lim, K MacAulay, S Jalkanen, D H Adams, P F Lalor

Gut Sep 2011, 60 (Suppl 2) A40-A41; DOI: 10.1136/gutjnl-2011-300857a.88
P96 Serum protein N-glycosylation as a biomarker of paediatric NAFLD
E Fitzpatrick, B Blomme, A Quaglia, R D Bruyne, H V Vlierberghe, A Dhawan

Gut Sep 2011, 60 (Suppl 2) A45; DOI: 10.1136/gutjnl-2011-300857a.96
OP11 Are simple non-invasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
S McPherson, Q Anstee, E Henderson, A Burt, C Day

Gut Sep 2011, 60 (Suppl 2) A54-A55; DOI: 10.1136/gutjnl-2011-300857b.11
Quantitative magnetic resonance imaging (MRI) in the evaluation of the degree of steatosis, iron accumulation and fibrosis in chronic liver diseases (MRKER STUDY)
C L Hoad, L Marciani, P Kaye, I N Guha, C Costigan, A Austin, R C Spiller, M W James, P A Gowland, S Francis, G P Aithal

Gut Apr 2011, 60 (Suppl 1) A55-A56; DOI: 10.1136/gut.2011.239301.110
Prevalence of abnormal liver function and response to lifestyle interventions in newly diagnosed type 2 diabetes: preliminary results of a UK randomised controlled study
R Parker, N Guthrie, N Patel, W Woltersdorf, R Andrews, C Dayan, C A McCune, Early ACTID

Gut Apr 2011, 60 (Suppl 1) A59; DOI: 10.1136/gut.2011.239301.117
PTU-131 Prevalence Of Abnormal Liver Functions Tests (lfts) In Obstructive Sleep Apnea (osa) Patients And Change In Lfts After Continuous Positive Airway Pressure (cpap) Therapy
R Haider, HJ O’Connor, M Azam

Gut Jun 2014, 63 (Suppl 1) A96; DOI: 10.1136/gutjnl-2014-307263.205

Main menu

Nonalcoholic steatosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Nonalcoholic steatosis

Pages